Polyclonal and monoclonal antibodies specific for ubiquitin-specific protease 20

Jang-Joon Park1, Ji-Hyun Yun, Kwang-Hyun Baek

  • 1Department of Biomedical Science, CHA University, CHA General Hospital, Seongnam, Republic of Korea.

Insights

Researchers developed new antibodies to study USP20, a deubiquitinating enzyme crucial for cellular functions like stabilizing HIF-1α and regulating NF-κB activation. These tools aid in understanding USP20

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cell Biology

Background:

  • Ubiquitination and deubiquitination are vital intracellular processes; their dysregulation is linked to diseases like cancer.
  • Deubiquitinating enzymes (DUBs) are key regulators, making them significant research targets.
  • USP20 (VDU2) is a DUB with established roles in stabilizing HIF-1α, regulating β2 adrenergic receptor recycling, and controlling NF-κB activation.

Purpose of the Study:

  • To generate and characterize antibodies against the deubiquitinating enzyme USP20.
  • To provide tools for investigating USP20's cellular functions and identifying novel substrates.

Main Methods:

  • Generation of a polyclonal antibody against USP20.
  • Development and characterization of two monoclonal antibodies targeting USP20.

Main Results:

  • Successfully generated and validated polyclonal and monoclonal antibodies specific to USP20.
  • These antibodies are suitable for research applications involving USP20.

Conclusions:

  • The developed USP20 antibodies are valuable reagents for further research into USP20's biological roles.
  • These tools will facilitate the investigation of USP20-mediated cellular mechanisms and the discovery of new USP20 substrates.

Related Concept Videos

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...